UB Paderborn / Katalog / Suche / in CDI

Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy

World journal of gastroenterology : WJG, 2006-06, Vol.12 (21), p.3297

2006

Link zum Volltext

Verfügbarkeit prüfen

Antibody targeted drugs as cancer therapeutics

Nature reviews. Drug discovery, 2006-02, Vol.5 (2), p.147-159

2006

Link zum Volltext

Verfügbarkeit prüfen

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG

Annals of oncology, 2006-04, Vol.17 (4), p.563-570

2006

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig

The New England journal of medicine, 2003-11, Vol.349 (20), p.1907-1915

2003

Link zum Volltext

Verfügbarkeit prüfen

Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e003198

2022

Link zum Volltext

Verfügbarkeit prüfen

New Insights into the Biological and Clinical Aspects of Merkel Cell Carcinoma

Cancers, 2021-05, Vol.13 (9), p.2259

2021

Link zum Volltext

Verfügbarkeit prüfen

Lack of clinical efficacy of imatinib in metastatic melanoma

British journal of cancer, 2005-04, Vol.92 (8), p.1398-1405

2005

Link zum Volltext

Verfügbarkeit prüfen

Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response

Cancer Immunology, Immunotherapy, 2002-10, Vol.51 (8), p.431-439

2002

Link zum Volltext

Verfügbarkeit prüfen

B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis

PloS one, 2007-02, Vol.2 (2), p.e236-e236

2007

Link zum Volltext

Verfügbarkeit prüfen

Current approaches to prevent NSAID‐induced gastropathy – COX selectivity and beyond

British journal of clinical pharmacology, 2004-12, Vol.58 (6), p.587-600

2004

Link zum Volltext

Verfügbarkeit prüfen

Regulators of apoptosis: suitable targets for immune therapy of cancer

Nature reviews. Drug discovery, 2005-05, Vol.4 (5), p.399-409

2005

Link zum Volltext

Verfügbarkeit prüfen

Role of matrix metalloproteinases in melanoma cell invasion

Biochimie, 2005-03, Vol.87 (3), p.307-314

2005

Link zum Volltext

Verfügbarkeit prüfen

Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients

Cancer research (Chicago, Ill.), 2001-08, Vol.61 (16), p.5964-5968

2001

Link zum Volltext

Verfügbarkeit prüfen

Process Monitoring in Grinding

CIRP annals, 2002, Vol.51 (2), p.551-571

2002

Link zum Volltext

Verfügbarkeit prüfen

Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients

Cancer research (Chicago, Ill.), 2001-02, Vol.61 (3), p.869-872

2001

Link zum Volltext

Verfügbarkeit prüfen

Expression of Stress-induced MHC Class I Related Chain Molecules on Human Melanoma

Journal of investigative dermatology, 2002-04, Vol.118 (4), p.600-605

2002

Link zum Volltext

Verfügbarkeit prüfen

Temozolomide in Combination With Interferon-Alfa Versus Temozolomide Alone in Patients With Advanced Metastatic Melanoma: A Randomized, Phase III, Multicenter Study from the Dermatologic Cooperative Oncology Group

Journal of clinical oncology, 2005-12, Vol.23 (35), p.9001-9007

2005

Link zum Volltext

Verfügbarkeit prüfen

Heme oxygenase-1 induction may explain the antioxidant profile of aspirin

Biochemical and biophysical research communications, 2003-09, Vol.308 (4), p.956-960

2003

Link zum Volltext

Verfügbarkeit prüfen

Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation

Cancer research (Chicago, Ill.), 2003-12, Vol.63 (23), p.8221-8225

2003

Link zum Volltext

Verfügbarkeit prüfen

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon α, and interleukin 2

British journal of cancer, 2002-10, Vol.87 (8), p.840-845

2002

Link zum Volltext

Verfügbarkeit prüfen

Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life

Journal of rheumatology, 2006-04, Vol.33 (4), p.681

2006

Link zum Volltext

Verfügbarkeit prüfen

Anorectal melanoma: surgical management guidelines according to tumour thickness

British journal of cancer, 2003-12, Vol.89 (11), p.2019-2022

2003

Link zum Volltext

Verfügbarkeit prüfen

Konstitutive BRaf Aktivierung im Melanom: Konsequenzen für Prognose und Therapie

Aktuelle Dermatologie, 2004, Vol.30 (8/09)

Becker, JC

2004

Link zum Volltext

Verfügbarkeit prüfen

Immune-Checkpoint-Blockade for Merkel Cell Carcinoma: Clinical and molecular Biomarker-Analysis

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, Vol.18, p.11

2020

Link zum Volltext

Verfügbarkeit prüfen

Loss of nonclassical MHC molecules MIC-A B expression during progression of uveal melanoma

British journal of cancer, 2004-10, Vol.91 (8), p.1495-1499

2004

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy

Antibody targeted drugs as cancer therapeutics

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG

Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig

Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma

New Insights into the Biological and Clinical Aspects of Merkel Cell Carcinoma

Lack of clinical efficacy of imatinib in metastatic melanoma

Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response

B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis

Current approaches to prevent NSAID‐induced gastropathy – COX selectivity and beyond

Regulators of apoptosis: suitable targets for immune therapy of cancer

Role of matrix metalloproteinases in melanoma cell invasion

Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients

Process Monitoring in Grinding

Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients

Expression of Stress-induced MHC Class I Related Chain Molecules on Human Melanoma

Temozolomide in Combination With Interferon-Alfa Versus Temozolomide Alone in Patients With Advanced Metastatic Melanoma: A Randomized, Phase III, Multicenter Study from the Dermatologic Cooperative Oncology Group

Heme oxygenase-1 induction may explain the antioxidant profile of aspirin

Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon α, and interleukin 2

Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life

Anorectal melanoma: surgical management guidelines according to tumour thickness

Konstitutive BRaf Aktivierung im Melanom: Konsequenzen für Prognose und Therapie

Immune-Checkpoint-Blockade for Merkel Cell Carcinoma: Clinical and molecular Biomarker-Analysis

Loss of nonclassical MHC molecules MIC-A B expression during progression of uveal melanoma

Suchergebnisse filtern